AirXpanders Announces First Patient Treated in IDE Trial of New Post-Mastectomy Tissue Expansion Device The XPAND trial will evaluate AeroForm™ as a possible alternative to standard tissue expansion in breast reconstruction process PALO ALTO, Calif. – December 5, 2011 – AirXpanders Inc., a company developing technology to address current unmet needs for patients who require […]
Peer-reviewed study published in Plastic and Reconstructive Surgery says device could “offer a new paradigm in breast reconstruction” PALO ALTO, Calif. (October, 2011) – AirXpanders Inc., a company developing technology to address current unmet needs for patients who require tissue expansion for reconstructive surgery, today announced new published data show that its AeroForm™ breast tissue […]
By AMANDA PEDERSEN Medical Device Daily Senior Staff Writer There has to be a better way. That sentiment is what inspired the development of a new breast tissue expansion device for mastectomy patients undergoing breast reconstruction. The device, called AeroForm, was developed by AirXpanders (Palo Alto, California), which recently received an investigational device exemption from […]
…to Begin Pivotal Study of an Investigational Tissue Expansion System for Women Undergoing Breast Reconstruction After Mastectomy Company to Launch Funding Round to Support AeroFormTM Through a Successful Commercial Launch PALO ALTO, CA–(Marketwire – Aug 29, 2011) – AirXpanders Inc., a company developing technology to address current unmet needs for patients who require tissue expansion […]
Please visit clinicaltrials.gov to see updated information about AirXpanders clinical trial (NCT01425268) in progress. Once the clinicaltrials.gov site pulls up, please type AirXpanders into the search box and you will be connected to the XPAND trial information posted there.